Expect New Cholesterol Injectables to Be Saved as Statin Add-Ons

September 2015

You'll hear buzz about "PCSK9 inhibitors" for high cholesterol, Praluent (PRAL-you-ent, alirocumab) and Repatha (ree-PATH-ah, evolocumab).

Health Canada will probably consider these for approval within the next year. Praluent has recently been approved in the U.S...and Repatha will soon follow.

These will be the first "biologic" injectable cholesterol meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Look Within Brand Names for Clues to a Med's Use
Obesity & Weight Loss Remind Patients to Pick Up Pen Needles With Saxenda Rxs
Nasal Sprays Expect More Third-Party Rejections On Nasacort Rxs
Cholesterol Expect New Cholesterol Injectables to Be Saved as Statin Add-Ons
Influenza Offer Flu Vaccines as Soon as You Have Them Available
Lice Point to "Directions for Use" on Lice Product Labelling
Constipation Apply a "Take On an Empty Stomach" Auxiliary Label to Movantik Rxs
Look-Alike/Sound-Alike Watch for Patients on "High-Alert" Meds Picking up Supplements
Antibiotics Consider Including Length of Therapy on Antibiotic Rx Labels
NSAIDs Stay Alert for Patients Taking Multiple Sources of NSAIDs
PPIs Alert the Pharmacist to Patients Using PPIs Over a Year
Dispensing Double-Check if Your Pharmacy Needs Certification to Dispense Risky Meds

Expect New Cholesterol Injectables to Be Saved as Statin Add-Ons

Practical advice for a better career, with unlimited access to CE

Table of Contents